Drug Metabolism Letters
Volume 14, 3 Issues, 2021
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
Contents
Drug Metabolism Letters, Volume 5 - Number 1
Effect of Pinocembrin Isolated from Boesenbergia pandurata on Xenobiotic-Metabolizing Enzymes in Rat Liver
, 5(1): 1 - 5Charatda Punvittayagul, Rawiwan Wongpoomchai, Sirinya Taya and Wilart Pompimon
DOI: 10.2174/187231211794455226
Inhibition of Cytochrome P450 1A2-Mediated Metabolism and Production of Reactive Oxygen Species by Heme Oxygenase-1 in Rat Liver Microsomes
, 5(1): 6 - 16James R. Reed, George F. Cawley and Wayne L. Backes
DOI: 10.2174/187231211794455253
An In Vitro, High Throughput, Seven CYP Cocktail Inhibition Assay for the Evaluation of New Chemical Entities Using LC-MS/MS
, 5(1): 17 - 24Jennifer N. Otten, Gary P. Hingorani, Dylan P. Hartley, Scott D. Kragerud and Ronald B. Franklin
DOI: 10.2174/187231211794455235
Mice Brain Nitric Oxide Synthase Response Induced by Anaesthetics and Other Porphyrinogenic Drugs
, 5(1): 25 - 29Jimena Lavandera, Alcira Batlle and Ana Maria Buzaleh
DOI: 10.2174/187231211794455271
A Comparative Study of the CYP450 Inhibition Potential of Marketed Drugs Using Two Fluorescence Based Assay Platforms Routinely Used in the Pharmaceutical Industry
, 5(1): 30 - 39Mahmud Kajbaf, Raffaele Longhi, Dino Montanari, Federica Vinco, Monica Rigo, Stefano Fontana and Kevin D. Read
DOI: 10.2174/187231211794455262
Statin Drugs, Metabolic Pathways, and Asthma: A Therapeutic Opportunity Needing Further Research
, 5(1): 40 - 44Amir A. Zeki, Nicholas J. Kenyon and Tzipora Goldkorn
DOI: 10.2174/187231211794455217
The Metabolism of Methazolamide - Identification of Metabolites in Guinea Pig Urine
, 5(1): 45 - 54Kenichi Kishida, Norihiro Yamamura, Yoshiaki Iwai, Yoshiteru Sakamoto, Makihiko Kuhara and Tetsuo Sasabe
DOI: 10.2174/187231211794455299
Comparative Pharmacokinetics and Metabolism Studies in Lean and Diet- Induced Obese Mice: An Animal Efficacy Model for 11β -Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors
, 5(1): 55 - 63Mengmeng Wang, Xianbin Tian, Louis Leung, Jianyao Wang, Nicole Houvig, Jason Xiang, Eddine Saiah, Seung Hahm, Vipin Suri and Xin Xu
DOI: 10.2174/187231211794455280
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serve as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net